Grant - In Vitro Diagnostic Solutions

Granted Over $7 Million Federal Funding

Since its 2017 inception, In Vitro Diagnostic Solutions has successfully secured and executed over $7 million in federal funding from the National Institutes of Health and the National Science Foundation. Through these programs, we have successfully demonstrated strong scientific feasibility and launched commercialization of several innovative chemistries in a universal platform that will transform the market and increase accessibility for point of care diagnostics across a wide spectrum of challenge diseases.

Diagnosis and Monitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)

$2,893,164

Principal Investigator : Robert Harper Disease Indication : G6PD

Umbel Microchip, a microfluidic-based blood analyzer

$115,000

Principal Investigator : Robert Harper & Shima Dalirirad Disease Indication : Blood Analyzer

Glucose-6-Phosphate Dehydrogenase (Phase I SBIR)

$191,220

Principal Investigator : Robert Harper Disease Indication : G6PD

Glucose-6-Phosphate Dehydrogenase (Phase II SBIR)

$1,447,330

Principal Investigator : Robert Harper Disease Indication: G6PD

Phenylalanine Determination (Phase I SBIR)

$224,700

Principal Investigator : Robert Harper Disease Indication : Phenylketonuria

Phenylalanine Determination (Phase II SBIR)

$1,946,957

Principal Investigator : Robert Harper Disease Indication : Phenylketonuria

Determination of the Bilirubin (Phase I SBIR)

$224,700

Principal Investigator : Robert Harper Disease Indication : Kernicterus

Simultaneous G6PD and Hemoglobin (Phase I SBIR)

$225,000

Principal Investigator : Robert Harper Disease Indication : G6PD

In Vitro Diagnostic Solutions is extremely grateful for the strong commercialization support provided by both the National Institute of Health and National Science Foundation Small Business Innovative Research Programs.